278 related articles for article (PubMed ID: 24193546)
1. Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen.
Favrot L; Grzegorzewicz AE; Lajiness DH; Marvin RK; Boucau J; Isailovic D; Jackson M; Ronning DR
Nat Commun; 2013; 4():2748. PubMed ID: 24193546
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the Mycobacterium tuberculosis antigen 85 complex by covalent, allosteric inhibitors.
Favrot L; Lajiness DH; Ronning DR
J Biol Chem; 2014 Sep; 289(36):25031-40. PubMed ID: 25028518
[TBL] [Abstract][Full Text] [Related]
3. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Mycobacterium tuberculosis transpeptidase Ldt
de Munnik M; Lohans CT; Lang PA; Langley GW; Malla TR; Tumber A; Schofield CJ; Brem J
Chem Commun (Camb); 2019 Aug; 55(69):10214-10217. PubMed ID: 31380528
[TBL] [Abstract][Full Text] [Related]
5. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial Activity of Ebselen.
Maślanka M; Mucha A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675123
[TBL] [Abstract][Full Text] [Related]
7. Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines.
Hanavan PD; Borges CR; Katchman BA; Faigel DO; Ho TH; Ma CT; Sergienko EA; Meurice N; Petit JL; Lake DF
Oncotarget; 2015 Jul; 6(21):18418-28. PubMed ID: 26158899
[TBL] [Abstract][Full Text] [Related]
8. Mycolyltransferase from
Goins CM; Dajnowicz S; Smith MD; Parks JM; Ronning DR
J Biol Chem; 2018 Mar; 293(10):3651-3662. PubMed ID: 29352107
[No Abstract] [Full Text] [Related]
9. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
10. The reaction of ebselen with peroxynitrite.
Masumoto H; Sies H
Chem Res Toxicol; 1996; 9(1):262-7. PubMed ID: 8924601
[TBL] [Abstract][Full Text] [Related]
11. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.
Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A
Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening using the differential radial capillary action of ligand assay identifies ebselen as an inhibitor of diguanylate cyclases.
Lieberman OJ; Orr MW; Wang Y; Lee VT
ACS Chem Biol; 2014 Jan; 9(1):183-92. PubMed ID: 24134695
[TBL] [Abstract][Full Text] [Related]
13. Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex.
Kuo CJ; Ptak CP; Hsieh CL; Akey BL; Chang YF
J Biol Chem; 2013 Feb; 288(6):3886-96. PubMed ID: 23250738
[TBL] [Abstract][Full Text] [Related]
14. Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapy.
Chantadul V; Wright GSA; Amporndanai K; Shahid M; Antonyuk SV; Washbourn G; Rogers M; Roberts N; Pye M; O'Neill PM; Hasnain SS
Commun Biol; 2020 Mar; 3(1):97. PubMed ID: 32139772
[TBL] [Abstract][Full Text] [Related]
15. Ebselen: Mechanisms of Glutamate Dehydrogenase and Glutaminase Enzyme Inhibition.
Yu Y; Jin Y; Zhou J; Ruan H; Zhao H; Lu S; Zhang Y; Li D; Ji X; Ruan BH
ACS Chem Biol; 2017 Dec; 12(12):3003-3011. PubMed ID: 29072450
[TBL] [Abstract][Full Text] [Related]
16. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
Jung CH; Washburn MP; Wells WW
Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antifungal and plasma membrane H+-ATPase inhibitory action of ebselen and two ebselen analogs in S. cerevisiae cultures.
Billack B; Pietka-Ottlik M; Santoro M; Nicholson S; Młochowski J; Lau-Cam C
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):312-7. PubMed ID: 20210698
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of ebselen.
Parnham MJ; Leyck S; Graf E; Dowling EJ; Blake DR
Agents Actions; 1991 Jan; 32(1-2):4-9. PubMed ID: 2058468
[No Abstract] [Full Text] [Related]
19. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Billack B; Santoro M; Lau-Cam C
Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523
[TBL] [Abstract][Full Text] [Related]
20. Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
Warrier T; Tropis M; Werngren J; Diehl A; Gengenbacher M; Schlegel B; Schade M; Oschkinat H; Daffe M; Hoffner S; Eddine AN; Kaufmann SH
Antimicrob Agents Chemother; 2012 Apr; 56(4):1735-43. PubMed ID: 22290959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
